Tonix Pharmaceuticals计划于2027年上半年在美国启动莱姆病预防性疫苗Tnx-4800的第二阶段适应性现场研究,需获FDA批准

美股速递
May 12

Tonix Pharmaceuticals Holding Co宣布,计划在2027年上半年于美国启动一项针对Tnx-4800疫苗的第二阶段适应性现场研究,旨在预防莱姆病。该计划的实施尚需与美国食品药品监督管理局达成最终协议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10